World's Best Scientists 2026 revealed!
Francisco Antunes

Francisco Antunes

D-Index & Metrics

Microbiology

D-Index
50
Citations
8868
World Ranking
4460
National Ranking
14

Francisco Antunes publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Francisco Antunes sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 170 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Francisco Antunes D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Francisco Antunes sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 50 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Francisco Antunes is affiliated with the University of Lisbon in Portugal and specializes primarily in the field of Medicine. Their research spans various subfields, including Epidemiology, Infectious Diseases, Virology, Food Science, and Molecular Biology.

The scientist's work focuses on several key topics:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • HIV/AIDS research and interventions
  • HIV, drug use, and sexual risk
  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research
  • Herpesvirus infections and treatments

Frequent co-authors in their research include Ana Virgolino, Raquel Sabino, Fernando Maltêz, Cristina Veríssimo, and Álvaro Pereira.

Publications have appeared across multiple journals, with frequent venues being the International Journal of Environmental Research and Public Health, Frontiers in Public Health, Healthcare, HIV Medicine, and Microorganisms.

Recent publications exemplify the scope of their research:

  • "Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?" (2020) in Microorganisms
  • "Monkeypox: From A Neglected Tropical Disease to a Public Health Threat" (2022) in Infectious Disease Reports
  • "Handling of Fresh Vegetables: Knowledge, Hygienic Behavior of Vendors, Public Health in Maputo Markets, Mozambique" (2020) in International Journal of Environmental Research and Public Health
  • "Persistence of IgG COVID-19 antibodies: A longitudinal analysis" (2023) in Frontiers in Public Health
  • "Towards a Global Perspective of Environmental Health: Defining the Research Grounds of an Institute of Environmental Health" (2020) in Sustainability

Best Publications

  • Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

    Deborah Konopnicki;Amanda Mocroft;S. De Wit;Francisco Antunes

  • Subgenotype Analysis of Cryptosporidium Isolates from Humans, Cattle, and Zoo Ruminants in Portugal

    Margarida Alves;Lihua Xiao;Irshad Sulaiman;Altaf A. Lal

  • AIDS across Europe, 1994–98: the EuroSIDA study

    A Mocroft;C Katlama;AM Johnson;C Pradier

  • Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

    Mocroft A;Brettle R;Kirk O;Blaxhult A

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

    Ole Kirk;Court Pedersen;Alessandro Cozzi-Lepri;Francisco Antunes

  • Changing incidence of central nervous system diseases in the EuroSIDA cohort

    Antonella D'Arminio Monforte;Paola Cinque;Amanda Mocroft;Frank Detlev Goebel

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal.

    Margarida Alves;Lihua Xiao;Francisco Antunes;Olga Matos

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results

    Jose Gatell;Dominique Salmon Ceron;Adriano Lazzarin;Eric Van Wijngaerden

  • Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.

    Joanne Reekie;Csaba Kosa;Frederik Engsig;Antonella d'Arminio Monforte

  • The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA study

    Amanda Mocroft;Ole Kirk;Nathan Clumeck;Panaglotis Gargalianos-Kakolyris

  • Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.

    Vincent Soriano;Perpétua Gomes;Walid Heneine;Africa Holguín

  • Epidemiology of AIDS dementia complex in Europe

    A. Chiesi;S. Vella;L. G. Dally;C. Pedersen

  • Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results

    Joel E. Gallant;Ellen Koenig;Jaime Andrade-Villanueva;Ploenchan Chetchotisakd

  • Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

    Alessandro Cozzi-Lepri;Andrew N Phillips;Lidia Ruiz;Bonaventura Clotet

  • Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.

    Maria Luísa Lobo;Lihua Xiao;Francisco Antunes;Olga Matos

  • Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

    Vicente Soriano;Keikawus Arasteh;Horacio Migrone;Thomas Lutz

  • Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?

    Raquel Filipa Pinheiro Sabino;Cristina Veríssimo;Cristina Veríssimo;Álvaro Ayres Pereira;Francisco Antunes

  • Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.

    Berta Rodés;Africa Holguín;Vincent Soriano;Manuela Dourana

  • Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

    Pedro Cahn;Jorge Villacian;Adriano Lazzarin;Christine Katlama

Frequent Co-Authors

Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Amanda Mocroft
Amanda Mocroft University College London
Andrzej Horban
Andrzej Horban Medical University of Warsaw
Lihua Xiao
Lihua Xiao South China Agricultural University
Christine Katlama
Christine Katlama Sorbonne University
José M. Gatell
José M. Gatell University of Barcelona
Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Nathan Clumeck
Nathan Clumeck Université Libre de Bruxelles
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Juan González-Lahoz
Juan González-Lahoz Instituto de Salud Carlos III

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to a variety of related online degrees and career pathways, especially for those looking to pivot within the healthcare or science fields. For individuals with unique circumstances, options like college degrees for felons provide accessible avenues to build new careers in science and healthcare.

One promising path includes roles in healthcare that blend science with patient care. Becoming a functional medicine nurse practitioner, for example, offers a competitive salary while allowing professionals to apply a science-based holistic approach to health.

Alternatively, many graduates pursue careers in healthcare administration or medical information management. The cpc medical coding salary reflects the growing demand for expertise in medical coding, an essential role in medical billing and records. Similarly, a role in healthcare information management salary underscores the increasing importance of managing patient data and healthcare systems efficiently.

Exploring these diverse career paths highlights the flexibility of a microbiology background paired with targeted online degrees, supporting both clinical and administrative roles in the broader healthcare industry.

Best Scientists Citing Francisco Antunes

Trending Scientists